2-[[5-[3-[[6-[[(5S)-5-Carboxy-5-[[(1S)-1,3-Dicarboxypropyl]Carbamoylamino]Pentyl]Amino]-6-Oxohexyl]Amino]-3-Oxopropyl]-2-Oxidophenyl]Methyl-[2-[[5-(2-Carboxyethyl)-2-Oxidophenyl]Methyl-(Carboxylatomethyl)Amino]Ethyl]Amino]Acetate:gallium-68(3+) Hydron

3 trials

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

2 Sponsors

2 Countries

Phase II

Phase II: 3

Sponsors using this IMP

Ospedale San Raffaele S.r.l. 2 Centre Hospitalier Regional Et Universitaire De Brest 1

All trials

3 total

The implementation of imaging guidance in surgery for patients with prostate cancer who are candidate to undergo robot-assisted prostatectom… Ended

2024-514583-12-00 Phase II 1 country Ospedale San Raffaele S.r.l.
A study of neoadjuvant PEMbrolizumab before radical PROstatectomy (PEM-PRO) in patients affected by high-risk prostate cancer Ended

2024-514580-26-00 Phase II 1 country Ospedale San Raffaele S.r.l.
Diagnostic Performance of Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) Imaging for Pr… Ended

2024-516319-25-00 Phase II 1 country Centre Hospitalier Regional Et Universitaire De Brest

Showing 1–3 of 3 trials

← All drugs A–Z